Hetal D. Marble

756 total citations
11 papers, 178 citations indexed

About

Hetal D. Marble is a scholar working on Physiology, Molecular Biology and Genetics. According to data from OpenAlex, Hetal D. Marble has authored 11 papers receiving a total of 178 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Physiology, 2 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Hetal D. Marble's work include Eosinophilic Disorders and Syndromes (2 papers), Cancer Genomics and Diagnostics (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Hetal D. Marble is often cited by papers focused on Eosinophilic Disorders and Syndromes (2 papers), Cancer Genomics and Diagnostics (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Hetal D. Marble collaborates with scholars based in United States, Netherlands and Australia. Hetal D. Marble's co-authors include Jochen K. Lennerz, Alexander Farahani, Eric M. Darling, Johannes G. Reiter, William R. Jeck, Onno Kranenburg, I‐Hsiu Lee, Martin S. Taylor, Wei‐Ting Hung and Emma C. E. Wassenaar and has published in prestigious journals such as Nature Medicine, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Hetal D. Marble

11 papers receiving 172 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hetal D. Marble United States 8 59 54 44 37 24 11 178
Martina Tufano Italy 9 102 1.7× 108 2.0× 31 0.7× 29 0.8× 18 0.8× 19 264
Siddharth Kunte United States 6 126 2.1× 65 1.2× 15 0.3× 34 0.9× 24 1.0× 13 227
Surita Dalal United Kingdom 6 48 0.8× 75 1.4× 17 0.4× 47 1.3× 35 1.5× 15 185
Julia Ellermann Germany 3 60 1.0× 119 2.2× 70 1.6× 28 0.8× 29 1.2× 3 251
Elizabeth W. Scadden United States 4 114 1.9× 88 1.6× 53 1.2× 35 0.9× 49 2.0× 9 249
Thomas Brouse United States 4 112 1.9× 112 2.1× 64 1.5× 40 1.1× 56 2.3× 6 275
Fiona E. Scott Australia 9 106 1.8× 42 0.8× 26 0.6× 12 0.3× 7 0.3× 23 221
Ester Cannizzaro Italy 9 14 0.2× 85 1.6× 15 0.3× 25 0.7× 28 1.2× 13 217
Sangeeth M. George United States 5 163 2.8× 37 0.7× 16 0.4× 9 0.2× 13 0.5× 10 216
Liana Veresezan France 7 90 1.5× 48 0.9× 70 1.6× 43 1.2× 12 0.5× 16 231

Countries citing papers authored by Hetal D. Marble

Since Specialization
Citations

This map shows the geographic impact of Hetal D. Marble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hetal D. Marble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hetal D. Marble more than expected).

Fields of papers citing papers by Hetal D. Marble

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hetal D. Marble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hetal D. Marble. The network helps show where Hetal D. Marble may publish in the future.

Co-authorship network of co-authors of Hetal D. Marble

This figure shows the co-authorship network connecting the top 25 collaborators of Hetal D. Marble. A scholar is included among the top collaborators of Hetal D. Marble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hetal D. Marble. Hetal D. Marble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Moiso, Enrico, Alexander Farahani, Hetal D. Marble, et al.. (2022). Developmental Deconvolution for Classification of Cancer Origin. Cancer Discovery. 12(11). 2566–2585. 12 indexed citations
2.
Malyavantham, Kishore S., Mary Brock, Hetal D. Marble, et al.. (2022). Validation of a fully automated lab developed test for plasma phospho‐tau 181 levels for Alzheimer’s disease diagnosis. Alzheimer s & Dementia. 18(S6). 1 indexed citations
4.
Lennerz, Jochen K., et al.. (2021). Do not sell regulatory science short. Nature Medicine. 27(4). 573–574. 3 indexed citations
5.
Mueller, Sarah B., Paola Dal Cin, Long P. Le, et al.. (2021). t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity. Blood Advances. 6(3). 818–827. 8 indexed citations
6.
Hobbs, Gabriela, Cansu Cimen Bozkus, Erin Moshier, et al.. (2021). PD-1 inhibition in advanced myeloproliferative neoplasms. Blood Advances. 5(23). 5086–5097. 27 indexed citations
7.
Reiter, Johannes G., Wei‐Ting Hung, I‐Hsiu Lee, et al.. (2020). Lymph node metastases develop through a wider evolutionary bottleneck than distant metastases. Nature Genetics. 52(7). 692–700. 70 indexed citations
8.
Marble, Hetal D., Sarah Dudgeon, Amanda Lowe, et al.. (2020). A Regulatory Science Initiative to Harmonize and Standardize Digital Pathology and Machine Learning Processes to Speed up Clinical Innovation to Patients. Journal of Pathology Informatics. 11(1). 22–22. 21 indexed citations
9.
Goyal, Lipika, Ángela Lamarca, John H. Strickler, et al.. (2020). The natural history of fibroblast growth factor receptor (FGFR)-altered cholangiocarcinoma (CCA).. Journal of Clinical Oncology. 38(15_suppl). e16686–e16686. 9 indexed citations
10.
Marble, Hetal D., et al.. (2017). Synthesis and Characterization of a Magnetically Active 19F Molecular Beacon. Bioconjugate Chemistry. 29(2). 335–342. 9 indexed citations
11.
Marble, Hetal D., et al.. (2014). Gene expression-based enrichment of live cells from adipose tissue produces subpopulations with improved osteogenic potential. Stem Cell Research & Therapy. 5(5). 145–145. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026